GPR15 Variants Cripple Novel CD8⁺ TIGR Cells Driving Severe Early-Onset IBD

Researchers have identified a distinct population of regulatory CD8+ T cells that homes to the colonic mucosa and keeps inflammatory macrophages in check, and they have linked rare, damaging variants in the homing receptor GPR15 to severe early-onset inflammatory bowel disease.

The work, published in Nature by Cui and colleagues, defines these cells as GPR15-guided regulatory CD8+ T cells — CD8+ TIGR cells — and shows they are molecularly and functionally separate from the peripheral KIR+CD8+ regulatory T cells described in other settings.

A Distinct Mucosal Regulator

Single-cell transcriptomics revealed an innate-like phenotype marked by NK-associated receptors including KIR2DL4, KIR3DL2, KLRC2 and KLRC3. In four unrelated families with severe early-onset IBD, whole-exome sequencing uncovered rare deleterious GPR15 variants.

Patient-derived cells showed variant-specific defects: D306N and Q281X were largely retained in the endoplasmic reticulum, Y215X showed minimal receptor expression, and Y132S and Y132S/F159I had reduced surface expression, while F159I alone localized normally to the Golgi and cell surface. Except for F159I, these defects reduced functional surface GPR15 and impaired GPR15L-directed chemotaxis.

Intestinal biopsies from these patients showed reduced CD8+ T cell frequencies in both epithelial and lamina propria compartments, a specific loss of the GPR15+ CD8+ TIGR cluster by scRNA-seq, and preserved FOXP3+ Treg frequencies — evidence of a non-overlapping regulatory layer. Patient tissue also accumulated activated macrophages.

Mouse Models Confirm the Causal Chain

Complementary mouse work identified a conserved murine CD8+ TIGR population expressing Ly49-family NK receptors such as Klra6 and Klra7. CD8+ T cell-specific Gpr15 deletion (Gpr15fl/flCd8cre), but not Treg-specific deletion (Gpr15fl/flFoxp3cre), selectively depleted colonic CD8+ TIGR cells and markedly worsened DSS-induced colitis. In Gpr15-deficient mice, inflammatory macrophages accumulated in the colon, and macrophage depletion attenuated colitis, supporting their pathogenic role.

Co-culture experiments showed that activated CD8+ TIGR cells directly eliminated inflammatory macrophages through a contact-dependent mechanism predominantly mediated by FasL and enhanced by TWEAK.

Relevance Beyond Monogenic Disease

The authors extended the findings to sporadic IBD cohorts. Colonic biopsies from ulcerative colitis patients showed a 42 percent decline in the CD8+ TIGR population, and terminal ileal biopsies from Crohn’s disease patients showed a significantly reduced population as well. The mechanism driving this reduction in sporadic disease remains unclear and cannot be solely attributed to impaired GPR15 signaling; other rate-limiting factors may be involved.

Unknowns Persist About Antigen Targets and Extra-Intestinal Roles

Several unknowns remain. GPR15-associated IBD shows incomplete penetrance — some carriers of deleterious variants remain asymptomatic — suggesting modulation by age, genetic background, or environment. The antigens recognized by CD8+ TIGR cells during inflammation are unknown despite a restricted T-cell receptor repertoire; it is unclear whether they recognize self, dietary, or microbial antigens. The study focused on intestinal tissue, so potential roles in extra-intestinal organs are unexplored.

Because GPR15 is also expressed by other intestinal T-cell populations, including γδ T cells, and has been implicated in pro-inflammatory CD4+ effector T-cell homing, non-selective systemic modulation could influence both protective and pathogenic lymphocyte trafficking. The authors suggest that cell-selective or mucosa-targeted approaches, guided by biomarkers identifying patients in whom GPR15-dependent CD8+ TIGR cell deficiency is rate-limiting, may be needed to safely restore intestinal immune homeostasis.